NØRAGER FYSIOTERAPI ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.7% 7.7% 3.6% 7.3% 5.5%  
Credit score (0-100)  61 32 51 33 35  
Credit rating  BBB BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,725 2,000 2,871 3,086 2,664  
EBITDA  381 -16.7 507 166 199  
EBIT  369 -34.1 482 144 187  
Pre-tax profit (PTP)  370.8 -39.0 478.1 137.0 185.0  
Net earnings  289.1 -31.1 372.7 105.8 145.9  
Pre-tax profit without non-rec. items  371 -39.0 478 137 185  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  37.1 84.8 60.3 38.2 26.1  
Shareholders equity total  629 18.9 392 167 196  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,065 786 1,014 705 637  

Net Debt  -553 -231 -496 -157 -195  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,725 2,000 2,871 3,086 2,664  
Gross profit growth  -17.9% 16.0% 43.5% 7.5% -13.7%  
Employees  6 6 7 7 6  
Employee growth %  0.0% 0.0% 16.7% 0.0% -14.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,065 786 1,014 705 637  
Balance sheet change%  7.7% -26.2% 29.0% -30.5% -9.6%  
Added value  381.5 -16.7 506.7 168.0 199.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -25 30 -49 -44 -24  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  21.4% -1.7% 16.8% 4.7% 7.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  36.1% -3.6% 53.6% 16.7% 27.9%  
ROI %  63.5% -10.4% 235.0% 51.4% 103.2%  
ROE %  49.5% -9.6% 181.6% 37.8% 80.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  59.0% 2.4% 38.6% 23.7% 30.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -145.1% 1,381.5% -97.9% -94.7% -97.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.2 0.8 1.4 1.1 1.3  
Current Ratio  2.4 0.9 1.5 1.2 1.4  
Cash and cash equivalent  553.5 231.1 496.2 156.8 194.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  591.8 -65.9 331.2 129.1 169.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  64 -3 72 24 33  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  64 -3 72 24 33  
EBIT / employee  61 -6 69 21 31  
Net earnings / employee  48 -5 53 15 24